secwatch.observer — SEC 8-K summary
======================================

Issuer:     TScan Therapeutics, Inc. (TCRX)
CIK:        0001783328
Form:       8-K
Filed at:   2025-09-09T23:59:59+00:00
Accession:  0001193125-25-198768
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TScan Therapeutics updates corporate presentation with adjusted timelines and pipeline updates
--------------------------------------------------------------------------------

- Company furnished updated corporate presentation on September 9, 2025 for investor meetings.
- Presentation includes adjusted timelines for solid tumor program and pipeline updates across hematologic malignancies and solid tumors.
- Updates on target discovery initiatives in autoimmunity also included; specific numerical details not disclosed in filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1783328/000119312525198768/0001193125-25-198768-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1783328/000119312525198768/d125738d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-198768

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer